<?xml version="1.0" encoding="UTF-8"?>
<p id="p0090">No children with nosocomial RSVreceived palivizumab –based prophylaxis prior to the onset of their infection. Retrospectively, such prophylaxis was not recommended for any of these children by the EMA, the French or the American guidelines.</p>
